ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Athenex Announces the US FDA Allowance of the Investigational New Drug Application of Oratopo, A Com
March 29, 2017Athenex, Inc. announced today that it has received United States Food and Drug Administration (US FDA) allowance to proceed into human clinical trials with the combination of oral topotecan and its proprietary P-glycoprotein (P-gp) inhibitor HM30181A.
Pharma Sources Insight January 2025
